| Negligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosol V De Matteis, MA Malvindi, A Galeone, V Brunetti, E De Luca, S Kote, ... Nanomedicine: Nanotechnology, Biology and Medicine 11 (3), 731-739, 2015 | 278 | 2015 |
| Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes HS Bhonsle, AM Korwar, SS Kote, SB Golegaonkar, AD Chougale, ... Journal of proteome research 11 (2), 1391-1396, 2012 | 105 | 2012 |
| Dissolution test for risk assessment of nanoparticles: a pilot study P Bove, MA Malvindi, SS Kote, R Bertorelli, M Summa, S Sabella Nanoscale 9 (19), 6315-6326, 2017 | 68 | 2017 |
| Mass spectrometry-based identification of MHC-associated peptides S Kote, A Pirog, G Bedran, J Alfaro, I Dapic Cancers 12 (3), 535, 2020 | 36 | 2020 |
| Analysis of AGE modified proteins and RAGE expression in HER2/neu negative invasive ductal carcinoma AM Korwar, HS Bhonsle, AD Chougale, SS Kote, KR Gawai, VS Ghole, ... Biochemical and biophysical research communications 419 (3), 490-494, 2012 | 32 | 2012 |
| The effects of IFITM1 and IFITM3 gene deletion on IFNγ stimulated protein synthesis M Gómez-Herranz, M Nekulova, J Faktor, L Hernychova, S Kote, ... Cellular signalling 60, 39-56, 2019 | 25 | 2019 |
| Functional interfaces, biological pathways, and regulations of interferon-related DNA damage resistance signature (IRDS) genes M Padariya, A Sznarkowska, S Kote, M Gómez-Herranz, S Mikac, M Pilch, ... Biomolecules 11 (5), 622, 2021 | 24 | 2021 |
| Autoimmunity and cancer—Two sides of the same coin J Sakowska, Ł Arcimowicz, M Jankowiak, I Papak, A Markiewicz, ... Frontiers in Immunology 13, 793234, 2022 | 22 | 2022 |
| The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276 R Li, P Zatloukalova, P Muller, M Gil-Mir, S Kote, S Wilkinson, AJ Kemp, ... Cellular & molecular biology letters 25, 1-21, 2020 | 16 | 2020 |
| Proteomic study reveals downregulation of apolipoprotein A1 in plasma of poorly controlled diabetes: a pilot study HS Bhonsle, AM Korwar, AD Chougale, SS Kote, NL Dhande, ... Molecular Medicine Reports 7 (2), 495-498, 2013 | 15 | 2013 |
| DIA-MS proteome analysis of formalin-fixed paraffin-embedded glioblastoma tissues K Weke, S Kote, J Faktor, S Al Shboul, N Uwugiaren, PM Brennan, ... Analytica Chimica Acta 1204, 339695, 2022 | 12 | 2022 |
| Comparison of different digestion methods for proteomic analysis of isolated cells and FFPE tissue samples A Pirog, J Faktor, Z Urban-Wojciuk, S Kote, E Chruściel, Ł Arcimowicz, ... Talanta 233, 122568, 2021 | 11 | 2021 |
| Structural determinants of peptide-dependent TAP1-TAP2 transit passage targeted by viral proteins and altered by cancer-associated mutations M Padariya, S Kote, M Mayordomo, I Dapic, J Alfaro, T Hupp, R Fahraeus, ... Computational and Structural Biotechnology Journal 19, 5072-5091, 2021 | 8 | 2021 |
| Analysis of venom sac constituents from the solitary, aculeate wasp Cerceris rybyensis S Kote, J Faktor, I Dapic, MY Mayordomo, M Kocikowski, A Kagansky, ... Toxicon 169, 1-4, 2019 | 5 | 2019 |
| The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides G Bedran, HC Gasser, K Weke, T Wang, D Bedran, A Laird, C Battail, ... Cancer immunology research 11 (6), 747-762, 2023 | 4 | 2023 |
| Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach A Singh, M Padariya, J Faktor, S Kote, S Mikac, A Dziadosz, TW Lam, ... Scientific Reports 12 (1), 19422, 2022 | 3 | 2022 |
| The effects of p53 gene inactivation on mutant proteome expression in a human melanoma cell model J Faktor, G Grasso, FZ Kokas, M Kurkowiak, MY Mayordomo, S Kote, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1864 (12), 129722, 2020 | 3 | 2020 |
| Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer M Gómez-Herranz, J Faktor, M Yébenes Mayordomo, M Pilch, ... Biomolecules 12 (8), 1090, 2022 | 2 | 2022 |
| SRSF1 as a novel interacting partner for IFITM1/3 unravels the emergent role of IFITM1/3 mediating protein expression M Gómez-Herranz, J Faktor, MY Mayordomo, M Pilch, L Hernychova, ... bioRxiv, 2022.02. 02.478792, 2022 | 1 | 2022 |
| Interferon Gamma, MHC class I regulation and immunotherapy M Gomez Herranz, M Pilch, T Hupp, S Kote Journal of Cellular Signaling 3 (1), 2022 | 1 | 2022 |
